Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2020

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue

Disaggregated revenue by payor type and major service line was as follows:

	Three Months Ended June 30, 2020
	Reporting Segment				Corporate and Other		Total
(in thousands)	Healthcare		Research
Payor/Service Line
Remote cardiac monitoring services - Medicare	$	33,281	$	—	$	—	$	33,281
Remote cardiac monitoring services - commercial payors	41,399		—		—		41,399
Clinical trial support and related services	—		11,459		—		11,459
Technology devices, consumables and related services	—		—		3,268		3,268
Subtotal	74,680		11,459		3,268		89,407
Other revenue	9,702		—		—		9,702
Total revenue	$	84,382	$	11,459	$	3,268	$	99,109

	Three Months Ended June 30, 2019
	Reporting Segment				Corporate and Other		Total
(in thousands)	Healthcare		Research
Payor/Service Line
Remote cardiac monitoring services - Medicare	$	36,096	$	—	$	—	$	36,096
Remote cardiac monitoring services - commercial payors	58,908		—		—		58,908
Clinical trial support and related services	—		13,879		—		13,879
Technology devices, consumables and related services	—		—		2,920		2,920
Total revenue	$	95,004	$	13,879	$	2,920	$	111,803

	Six Months Ended June 30, 2020
	Reporting Segment				Corporate and Other		Total
(in thousands)	Healthcare		Research
Payor/Service Line
Remote cardiac monitoring services - Medicare	$	73,409	$	—	$	—	$	73,409
Remote cardiac monitoring services - commercial payors	96,978		—		—		96,978
Clinical trial support and related services	—		25,279		—		25,279
Technology devices, consumables and related services	—		—		6,772		6,772
Subtotal	170,387		25,279		6,772		202,438
Other revenue	9,702		—		—		9,702
Total revenue	$	180,089	$	25,279	$	6,772	$	212,140

	Six Months Ended June 30, 2019
	Reporting Segment				Corporate and Other		Total
(in thousands)	Healthcare		Research
Payor/Service Line
Remote cardiac monitoring services - Medicare	$	70,031	$	—	$	—	$	70,031
Remote cardiac monitoring services - commercial payors	112,982		—		—		112,982
Clinical trial support and related services	—		26,843		—		26,843
Technology devices, consumables and related services	—		—		5,926		5,926
Total revenue	$	183,013	$	26,843	$	5,926	$	215,782

Disaggregation of Allowance for Credit Losses

Disaggregated allowance by portfolio was as follows:

	Three Months Ended June 30, 2020
	Portfolio						Total
(in thousands)	Healthcare			Other
Beginning balance	$	37,980		$	548		$	38,528
Current period credit loss expense*	6,105			61			6,166
Write-offs	(6,555		)	(67		)	(6,622		)
Ending Balance	$	37,530		$	542		$	38,072